PROCEPT BioRobotics (PRCT) Operating Margin (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Operating Margin data on file, last reported at 39.22% in Q1 2026.

• Operating Margin for Q1 2026 came in at 39.22%, up 45.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 33.86% (up 484.0% YoY), and the FY2025 annual result was 33.71%, up 932.0% from the prior year.
• Operating Margin grew to 39.22% in Q1 2026 per PRCT's latest filing, from 40.64% in the prior quarter.
• Over five years, Operating Margin peaked at 27.83% in Q3 2025 and troughed at 116.28% in Q1 2023.
• A 5-year average of 65.95% and a median of 62.08% in 2024 frame the typical range for Operating Margin.
• The sharpest annual moves came in 2022 and 2025: Operating Margin soared 6071 bps in 2022, then sank 1175 bps in 2025.
• A 5-year view of Operating Margin shows it stood at 105.31% in 2022, then surged by 36 bps to 67.82% in 2023, then soared by 57 bps to 28.89% in 2024, then plunged by 41 bps to 40.64% in 2025, then gained by 3 bps to 39.22% in 2026.
• Business Quant data shows PRCT's Operating Margin at 39.22% in Q1 2026, 40.64% in Q4 2025, and 27.83% in Q3 2025.